Repeated nasal congestion, don't think it is rhinitis!

Home > Health

Repeated nasal congestion, don't think it is rhinitis!

2022-01-28 12:05:51 25 ℃

There is such a case, it is worth alert!

Mr. Zhang is 64 years old, smoking history for more than 30 years, in August 2021, there is still a stuffy nasal congestion, sometimes there is dizzy, he thinks it is rhinitis, so he did not go to the hospital. The right neck has a painless mass, which is approaching the hospital.

The electronic fiber noseoscopy, found new creatures of nasopharyngeal, nasopharyngeal new biological test, pathological reminds: "non-corned squamous cell carcinoma", nasopharyngeal CT flat sweep: "Right side nasopharyngeal cavity See soft tissue mass, size of about 32.4mm × 18.1mm, " Doctor diagnosis Mr. Zhang is the late nasopharyngeal carcinoma.

In the early October 2021, Mr. Zhang came to our hospital in hospital hospitalization treatment, Director of Oncology, Director of Oncology, Xu Xiang Lifa, Department of Radiothe, Wu Ling, a drug, Mr. Zhang, has set a detailed synchronous emission treatment + consolidation of chemotherapy solutions, A total of 34 times of radiotherapy.

After radiotherapy and four-week TP program chemotherapy, Mr. Zhang's nasal congestion, blood disappear, the nasopharyngeal block is significantly reduced, review the nasopharyngeal CT smoothness (due to metal in patients, there is no magnetic resonance check): soft tissue package The block was reduced by 32.4 mm × 18.1 mm of 27 mm × 13 mm. The right neck mass is also significantly reduced, review the full body shallow lymph node color hypothesis: the right neck lymph node is reduced from 40 mm × 28 mm to 21 mm × 24 mm. The patient's condition is significantly improved, and the next step will continue to consolidate chemotherapy.

Popular link

What is nasopharyngeal cancer?

Nasopharyngeal carcinoma refers to a malignant tumor that occurs on top of the nasopharyngeal chamber and a side wall. It is one of my country's high malignant tumors, and the incidence is the first of the otolaryngioma. Common clinical symptoms are nasal congestion, blood, the ear, the sense of hearing, re-facet and headache.

When nasopharyngeal carcinoma is coming, the body will issue these four warning signals:

1, nasal congestion, back suction nose with blood. The initial symptoms of nasopharyngeal carcinoma are not large, and it is easy to cause misconduct, so if there is an unknown reason, the symptoms of blood are born, must go to the hospital early.

2, headache and double look.

3, hearing declines and difficulties in the mouth.

4, lymph node painless swelling.

Most of the nasopharyngeal carcinoma has moderate sensitivity to radiation therapy, radiotherapy is the preferred treatment of nasopharyngeal carcinoma. However, comprehensive treatment of chemotherapy, molecular targeting, immunotherapy, and traditional Chinese medicine, etc. With the current diagnosis and treatment techniques and means, the survival rate of nasopharyngeal carcinoma after chemotherapy can reach more than 70%, and if early detection, it can be further increased to 80 to 90%. Therefore, it is recommended that the nasopharyngeal carcinoma screening should be performed regularly for the middle-aged population with family history or smoking history, the sooner, the better the prognosis.

Some graphic is derived from the network, used for science knowledge communication, if there is infringement, please contact it.

Introduction to Tumor Introduction

The tumor interpare is located on the 3rd floor of the Ca District of the Department of Hospital, which is provided with a tumor treatment center, a tumor radiotherapy center, a thoracic and abdomen aqueous treatment center, and a cancer treatment center. Configure advanced equipment such as high-frequency thermal treatment machines, relying on the radiotherapy center, the department takes the MDT multi-discipline joint diagnosis and treatment model, with tumor chemotherapy, radiotherapy, targeted therapy, immunotherapy, heat, etc., improve tumor comprehensive treatment Ability, let tumor patients get better treatment. In clinical, scientific research, academic and southwestern hospitals, Xinqiao Hospital, Daping Hospital, Heavy Medicine, Heavy Medicine attached to Second Hospital, Chongqing Cancer Hospital, etc. Tree hospitals for a long time. In 2018, he became a member of the China Hematology Specialist Alliance, and 2020 became a Chinese expert alliance in China.

The department has widely carried out CT or B-ultrasound, lung, liver, pancreatic, kidney and adrenal, abdominal abdominal abdominal, bone marrow puncture and biopsy, bone marrow puncture and biopsy Tube. Early diagnosis, standardized radiotherapy and chemotherapy of various malignant tumors (new auxiliary chemotherapy, adjuvant chemotherapy, maintenance chemotherapy, chest and abdominal drug perfusion chemotherapy), molecular targeted treatment, immunomogenic anti-treatment, traditional Chinese medicine treatment, tumor pain Standardized ladder pain relief treatment, advanced tumor palliative treatment and comprehensive conditioning treatment. The department follows the principle of tumor individualization and comprehensive treatment, based on evidence-based medical philosophy, in tumors, lung cancer, breast cancer, esophageal cancer, gastric cancer, liver cancer, gallbladder cancer, pancreatic cancer, intestinal cancer, ovarian cancer, uterus Inneri cancer, intracranial tumor, multiple myeloma, malignant lymphoma, bone and soft tissue tumors, leukemia, bone marrow proliferative abnormal syndrome, and a variety of anemia diagnosis and treatment have rich clinical experience.

Expert profile

Left Wen Wei

Digestion, Director of Tumor Biversity

Deputy Chief Physician

Zuo Wewei, Chongqing Sanbo Chang'an Hospital Director (Digestion, Cancer Internal Medicine) Director, Deputy Chief Physician, University Education, a Bachelor's degree. In June 1996, he graduated from the Southwest Medical University (formerly "Medical College in Southwest Medical University.